Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06831513 · ClinicalTrials.gov registry record · NA

Observe the Effects of the Serkel Cranial Remolding Orthosis on Infants With Deformational Plagiocephaly

A NA study, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT06831513 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06831513, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

The purpose of this study is to determine the safety and effectiveness of a specific brand of cranial remolding orthosis (a custom made helmet), which is new to the United States market

Interventions

  • DEVICE Serkel 3D CRO

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2022-05-24
Est. Completion 2024-04-05
Phase NA

What the Registry Record Tells You About NCT06831513

The ClinicalTrials.gov registry entry for NCT06831513 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Serkel 3D CRO is the first listed.

NCT06831513 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06831513 about?

NCT06831513 is a clinical study titled "Observe the Effects of the Serkel Cranial Remolding Orthosis on Infants With Deformational Plagiocephaly". The purpose of this study is to determine the safety and effectiveness of a specific brand of cranial remolding orthosis (a custom made helmet), which is new to the United States market

What is the current status of trial NCT06831513?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-05-24. Estimated completion is 2024-04-05.

What interventions are being tested in trial NCT06831513?

The interventions under investigation include: Serkel 3D CRO (DEVICE).

Who is sponsoring clinical trial NCT06831513?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.